Marrone Bio Innovations Submits Grandevo Bioinsecticide for Mexican Registration

Grandevo_NO-tag_RGB_sm_FOR_POSTINGMarrone Bio Innovations, Inc. (MBI)[NASDAQ: MBII], a leading global provider of bio-based pest management and plant health products announced it has submitted GRANDEVO® bioinsecticide for registration in Mexico. GRANDEVO controls a broad spectrum of insects and mites in a wide variety of agricultural crops. Upon registration, it will join REGALIA® MAXX biofungicide, the first MBI product registered in Mexico, in providing growers a high level of crop protection with the benefits of a bio-based product.  more »

Marrone Bio Innovations Submits Biofumigant for EPA Registration

A biological alternative to toxic fumigants

Marrone Bio Innovations, Inc. (MBI) [NASDAQ: MBII], a leading global provider of bio-based pest management and plant health products announced it has submitted MBI-601 EP, a biofumigant, to the United States Environmental Protection Agency (EPA) for registration. The product controls and suppresses plant parasitic nematodes, insect pests and soil-borne plant diseases in agricultural and horticultural soils. The active ingredient, Muscodor albus strain SA 13, produces volatile compounds that inhibit the growth of or kill economically important pests and plant diseases. It targets the most destructive species of nematodes—root knot, sting, ring, spiral, cyst, lance, and lesion and also the highly-damaging plant diseases Fusarium root rot, damping off, southern blight and Verticillium wilt.  With this control, field trials show increased yields in treated strawberries, lettuce and other crops.

“We expect MBI-601 to fill a real need for high value fruit, vegetable, and ornamental growers. Soil fumigants have been valuable tools in protecting these crops worldwide and making their production economically feasible. However, many fumigants have been restricted or removed from the market due to increased regulatory restrictions and concerns about their toxicity to humans and the environment,” explains Jim Lappin, MBI’s VP of Product Management and Business Development.

“MBI-601, a naturally occurring, biologically-based fumigant, will provide an alternative to the traditional synthetic materials. In fact, it is anticipated that workers can return to the treated acres quickly after the product has been applied and planting the crop after application will be shorter than with traditional fumigants. Additional uses in the future, as we further develop the product may include post-harvest, turf, silviculture and seed treatments,” adds Lappin.

MBI-601 is the seventh new active ingredient submitted by MBI to the EPA. “MBI continues to execute on its strategy of rapid development of multiple products across the full range of customer needs. With the losses and restrictions of chemical fumigants, biologicals have the potential to help fill an unmet market need,” said Pam Marrone, the company’s CEO.

***

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental, and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements relating to market size and the results from the field trials.  Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the difficulty in predicting the outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the in the Form 10-K that the Company filed with the Securities and Exchange Commission on March 25, 2014.

REGALIA® MAXX Biofungicide Receives Registration In Peru

Residue-Exempt Biopesticide Could Help Boost Table Grapes Exports to the U.S. and Europe

Marrone Bio Innovations, Inc. (MBI) [NASDAQ: MBII], a leading global provider of bio-based pest management and plant health products, announced FMC, the exclusive Latin America distributor for its REGALIA® MAXX Biofungicide, has received a product registration in Peru. Peru now joins El Salvador, Guatemala, Honduras, Panama and Mexico as Latin America countries having approved the use of REGALIA MAXX to control a wide variety of bacterial and fungal diseases across an array of agricultural crops.  more »

Marrone Bio Innovations Hires VP of Technology Development

Marrone Bio Innovations, Inc. (MBI) [NASDAQ: MBII], a leading global provider of bio-based pest management and plant health products announced it has hired Amit Vasavada, Ph.D., as Vice President of Technology Development, a newly created position within the company. Dr. Vasavada brings 30 years of experience in industrial bioproducts, fermentation R&D and manufacturing, process engineering, and technology transfer to MBI. His broad commercial background includes positions with General Atomics, Vical Inc., Diversa Corporation, Monsanto (CP Kelco), and Chiron Corp.  more »

Marrone Bio Innovations Hires General Counsel

Marrone Bio Innovations, Inc. (MBI)[NASDAQ: MBII], a leading global provider of bio-based pest management and plant health products announced it has hired Linda V. Moore in the newly created general counsel position. She previously served as General Counsel and Chief Compliance Officer for Merix Corp., Phoenix Technologies, and Jabil Circuit, in addition to being co-founder and principal of The Moore Group. Moore brings extensive experience in the areas of intellectual property, securities regulations and compliance, corporate governance, labor relations, and litigation management. She also has managed international tax, labor, and facilities issues with expatriate and extended assignments in Europe, Asia and Latin America.

“Linda brings a very valuable set of skills to MBI. Her broad corporate experience in the critical issues facing a rapidly growing company such as ours is outstanding. She will be a great addition to our leadership team,” comments Pam Marrone, CEO of Marrone Bio Innovations. She adds, “And, as MBI continues to expand outside the U.S. her background in international operations will become increasingly more important.”

Moore earned her J.D. at Michigan State University School of Law.

*****

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental, and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Marrone Bio Innovations Receives Patent Surrounding Regalia® Biofungicide

Marrone Bio Innovations, Inc. (MBI)[NASDAQ: MBII], a leading global provider of bio-based pest management and plant health products announced it has received a United States patent covering applications of products containing anthraquinone derivatives, such as the company’s flagship product Regalia® Biofungicide. The issued claims cover methods for increasing plant growth, root initiation and extension when plant roots are treated with an anthraquinone derivative. The new patent protects uses of Regalia and any future MBI products containing these active ingredients.  more »

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. ...
  10. 19